Stay updated on Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T01:48:50.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.3%
    Check dated 2025-01-12T22:29:29.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:08:09.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for those interested in joining the study, along with a reference to the Contacts and Locations section in the How to Read a Study Record.
    Difference
    3%
    Check dated 2024-12-07T17:43:04.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The website has added new features for user interaction, while several detailed data fields and options for downloading study information have been removed.
    Difference
    4%
    Check dated 2024-11-23T05:17:14.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    New content has been added, including updates from November 2024 and a Plain Language Summary, while several entries from August 2022 have been removed.
    Difference
    1%
    Check dated 2024-11-16T00:40:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page.